Isradipine
(Redirected from Rebriden)
Isradipine is a type of calcium channel blocker used primarily in the treatment of hypertension. It belongs to the dihydropyridine class of calcium channel blockers, which also includes drugs such as amlodipine, nifedipine, and felodipine.
Pharmacology[edit | edit source]
Isradipine works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle. It does this by binding to L-type calcium channels, which are the primary type of voltage-gated calcium channels in these tissues. By blocking these channels, isradipine prevents calcium-dependent contraction of the muscle cells, leading to relaxation and dilation of the blood vessels. This results in a decrease in blood pressure.
Clinical Use[edit | edit source]
Isradipine is primarily used in the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. Isradipine has also been investigated for use in the treatment of Parkinson's disease, due to its ability to block calcium channels in neurons, but results have been inconclusive.
Side Effects[edit | edit source]
Common side effects of isradipine include headache, dizziness, flushing, and edema. Less common but more serious side effects can include hypotension, tachycardia, and heart failure.
Contraindications[edit | edit source]
Isradipine is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers. It should also be used with caution in patients with severe cardiac disease, as it can exacerbate symptoms of heart failure.
Drug Interactions[edit | edit source]
Isradipine can interact with a number of other drugs, including beta blockers, digoxin, and cimetidine. These interactions can lead to changes in the effectiveness of isradipine or the interacting drug, and may require dose adjustments.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
